Tectonic Therapeutic Inc (TECX) has a current Price-to-Book (P/B) ratio of 1.46. Compared to its 3-year average P/B ratio of 2.11, the current P/B ratio is approximately -30.61% higher. Relative to its 5-year average P/B ratio of 2.11, the current P/B ratio is about -30.61% higher. Tectonic Therapeutic Inc (TECX) has a Forward Free Cash Flow (FCF) yield of approximately -16.01%. Compared to its 3-year average FCF yield of -14.63%, the current FCF yield is approximately 9.41% lower. Relative to its 5-year average FCF yield of -14.63%, the current FCF yield is about 9.41% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TECX competitors is 1.11, providing a benchmark for relative valuation. Tectonic Therapeutic Inc Corp (TECX.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TECX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TECX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TECX currently overvalued or undervalued?

What is Tectonic Therapeutic Inc (TECX) fair value?

TECX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Tectonic Therapeutic Inc (TECX) is between to according to relative valuation method.

How does TECX's valuation metrics compare to the industry average?

The average P/S ratio for TECX's competitors is 1.11, providing a benchmark for relative valuation. Tectonic Therapeutic Inc Corp (TECX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Tectonic Therapeutic Inc (TECX) as of Mar 03 2026?

As of Mar 03 2026, Tectonic Therapeutic Inc (TECX) has a P/B ratio of 1.46. This indicates that the market values TECX at 1.46 times its book value.

What is the current FCF Yield for Tectonic Therapeutic Inc (TECX) as of Mar 03 2026?

As of Mar 03 2026, Tectonic Therapeutic Inc (TECX) has a FCF Yield of -16.01%. This means that for every dollar of Tectonic Therapeutic Inc's market capitalization, the company generates -16.01 cents in free cash flow.

What is the current Forward P/E ratio for Tectonic Therapeutic Inc (TECX) as of Mar 03 2026?

As of Mar 03 2026, Tectonic Therapeutic Inc (TECX) has a Forward P/E ratio of -4.19. This means the market is willing to pay $-4.19 for every dollar of Tectonic Therapeutic Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Tectonic Therapeutic Inc (TECX) as of Mar 03 2026?

As of Mar 03 2026, Tectonic Therapeutic Inc (TECX) has a Forward P/S ratio of 0.00. This means the market is valuing TECX at $0.00 for every dollar of expected revenue over the next 12 months.

TECX Valuation